1. Home
  2. SEMR vs MIRM Comparison

SEMR vs MIRM Comparison

Compare SEMR & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • MIRM
  • Stock Information
  • Founded
  • SEMR 2008
  • MIRM 2018
  • Country
  • SEMR United States
  • MIRM United States
  • Employees
  • SEMR N/A
  • MIRM N/A
  • Industry
  • SEMR EDP Services
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEMR Technology
  • MIRM Health Care
  • Exchange
  • SEMR Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • SEMR 1.4B
  • MIRM 2.5B
  • IPO Year
  • SEMR 2021
  • MIRM 2019
  • Fundamental
  • Price
  • SEMR $9.12
  • MIRM $49.09
  • Analyst Decision
  • SEMR Buy
  • MIRM Strong Buy
  • Analyst Count
  • SEMR 8
  • MIRM 9
  • Target Price
  • SEMR $17.00
  • MIRM $66.22
  • AVG Volume (30 Days)
  • SEMR 922.7K
  • MIRM 449.1K
  • Earning Date
  • SEMR 08-04-2025
  • MIRM 08-06-2025
  • Dividend Yield
  • SEMR N/A
  • MIRM N/A
  • EPS Growth
  • SEMR N/A
  • MIRM N/A
  • EPS
  • SEMR 0.05
  • MIRM N/A
  • Revenue
  • SEMR $396,021,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • SEMR $21.84
  • MIRM $35.83
  • Revenue Next Year
  • SEMR $18.46
  • MIRM $16.83
  • P/E Ratio
  • SEMR $191.83
  • MIRM N/A
  • Revenue Growth
  • SEMR 22.75
  • MIRM 69.31
  • 52 Week Low
  • SEMR $7.90
  • MIRM $33.45
  • 52 Week High
  • SEMR $18.74
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 43.42
  • MIRM 53.95
  • Support Level
  • SEMR $8.74
  • MIRM $49.39
  • Resistance Level
  • SEMR $9.18
  • MIRM $51.93
  • Average True Range (ATR)
  • SEMR 0.30
  • MIRM 1.53
  • MACD
  • SEMR 0.01
  • MIRM -0.27
  • Stochastic Oscillator
  • SEMR 46.15
  • MIRM 31.40

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: